Hollister Lietuva UAB

Hollister Lietuva UAB is the Lithuanian subsidiary of Hollister Incorporated, a privately held, global medical device manufacturer headquartered in Libertyville, Illinois, United States. The Lithuanian operation is focused on manufacturing and supply-chain activities for ostomy and continence care products and forms part of Hollister’s European production footprint.

Company Overview

Legal name: Hollister Lietuva UAB
Industry: Medical devices (Ostomy care, Continence care, related accessories)
Founding in Lithuania: Established in the mid‑2010s (publicly available sources place the incorporation and construction preparation in the 2015–2017 timeframe; exact registration date should be confirmed in the Juridinių asmenų registras).
Headquarters (Lithuania): Located in the Kaunas region, in or adjacent to the Kaunas Free Economic Zone (Kauno LEZ). Precise street address is noted below if/when verified.

Legal Information

Įmonės kodas (company registration code): Not publicly verified in the sources accessible here. To confirm, search “Hollister Lietuva UAB” in the Juridinių asmenų registras (Registrų centras) or consult Rekvizitai.lt.
PVM kodas (VAT code): Not publicly verified here. Typically formatted LTXXXXXXXXX. Verification recommended via VMI (Valstybinė mokesčių inspekcija) or official registry extracts.
Official website: https://www.hollister.com
Email address: Not publicly listed for the Lithuanian entity in the sources accessible here. Hollister generally directs inquiries through its website contact form; local HR or plant contacts are often provided in job postings but could not be verified.
Registered office address: Kaunas region, Kauno LEZ (Biruliškės, Kaunas district). The precise street address is not confirmed in the sources accessible here and should be verified in Registrų centras or on official Hollister Lietuva communications.
Phone number: Not publicly verified for the Lithuanian entity. Check official registry extracts or the company’s public materials.

Business Operations

Main products and services:
- Ostomy care: pouches, barrier wafers, skin barriers, accessories (e.g., CeraPlus technology range, New Image, Moderma Flex lines, Adapt accessories).
- Continence care: intermittent catheters and related continence management products (e.g., VaPro, Advance/Apogee family lines).
- Supporting manufacturing, assembly, packaging, and logistics for EMEA distribution.

Business model: Design, manufacture, and distribution of specialized medical devices sold to hospitals, clinics, healthcare providers, distributors, and directly to patients via healthcare channels. The Lithuanian subsidiary is a production and operations hub supporting Hollister’s global supply chain.

Market position: Hollister Incorporated is widely recognized as a leading, specialist manufacturer in ostomy and continence care, commonly cited among the top global players in these niches.

History

Origins: Hollister Incorporated was founded in 1921 by John Dickinson Schneider in the United States. It is privately held and has grown into a global medical technology company.

Establishing Hollister Lietuva: In the mid‑2010s, Hollister selected Lithuania—specifically the Kaunas region and Kaunas Free Economic Zone—due to its growing medical manufacturing ecosystem, skilled workforce, and favorable investment conditions. Ground‑breaking and construction milestones were reported during 2016–2018, with initial production lines commencing thereafter (commonly referenced as 2018–2019). Subsequent phases of expansion have been reported through the early 2020s to scale capacity and broaden the product lines manufactured in Lithuania.

Financial Information

Revenue (Lithuania): Subsidiary-level revenue figures may be available through Lithuanian corporate registries or business directories (e.g., Rekvizitai.lt). They were not accessible in the sources reviewed here.

Global revenue: Hollister Incorporated is privately held and does not routinely publish consolidated revenue figures.

Funding rounds: Not applicable; Hollister is privately owned and typically funds expansion from internal resources.

Ownership structure: Hollister Lietuva UAB is a wholly owned subsidiary within Hollister’s international corporate structure. Ultimate control is by Hollister Incorporated (USA).

Leadership and Management

Local executives (vadovai): The statutory manager (vadovas) and local leadership names/roles for Hollister Lietuva UAB were not publicly verifiable in the sources available here. These are listed in the Juridinių asmenų registras and in official corporate filings.

Global leadership (Hollister Incorporated): The company’s senior leadership includes a President/CEO and executive team overseeing global operations, manufacturing, and commercial functions. Specific name assignments can change; consult the Hollister corporate website for the current roster.

Board members: Board composition for the Lithuanian entity was not publicly verified here; consult official filings.

Office Locations

Primary site (Lithuania): Manufacturing facility in the Kaunas region, associated with Kauno LEZ (Biruliškės, Kaunas district).
Address and phone numbers: Exact street address and phone numbers were not verified in the sources accessible here. Please confirm via Registrų centras, Rekvizitai.lt, or Hollister’s official communications.

Market Position

Competitors: Coloplast, Convatec, B. Braun (Aesculap), and other specialized medical device companies focused on ostomy, continence, and wound/skin care solutions.

Market share: Precise market share figures are not publicly disclosed. Industry analysts frequently place Hollister among the top global suppliers in ostomy and continence care.

Competitive advantages: Focused specialization in ostomy and continence care; long-standing clinician and patient engagement; product innovation (e.g., CeraPlus skin barrier technology, hydrophilic catheter technology); quality manufacturing footprint across the US and Europe; strong training and patient education programs.

Recent Developments

- Continued scaling and optimization of production activities in Lithuania through the early 2020s to support EMEA demand.
- Ongoing recruitment and workforce development in engineering, quality, production, and supply chain roles.
- Reported collaboration with Kaunas FEZ/Kauno LEZ stakeholders and Invest Lithuania on investment facilitation and talent pipelines.
- Sustainability and quality initiatives (e.g., ISO certifications) typical of medical device manufacturing; specific certifications for the Lithuanian plant should be verified in the company’s quality and regulatory communications.

Contact Information

Hollister Lietuva UAB (Lithuania):
Address: Kaunas region, Kauno LEZ (Biruliškės, Kaunas district). Exact street address not verified here.
Phone: Not verified; consult official sources.
Email: Not publicly listed; contact via Hollister’s website.

Corporate (Hollister Incorporated):
Website: https://www.hollister.com
Global contact: Company uses regional contact forms and customer service lines listed on its website; local EMEA support details are provided there.

Sources and References

Note: The Lithuanian entity’s legal identifiers (įmonės kodas, PVM kodas), exact address, and phone numbers are best obtained from official registries and the company’s own disclosures. The following public sources underpin the general profile above:

- Hollister Incorporated – Corporate website (company overview, product families, global footprint)
- Invest Lithuania – Press releases and investment case studies referencing Hollister’s decision to locate manufacturing in Kaunas region (mid‑2010s onward)
- Kaunas Free Economic Zone (Kauno LEZ) – News and tenant information referencing Hollister Lietuva activities and expansions
- Registrų centras (Juridinių asmenų registras) – Official corporate registry for Lithuania (legal codes, directors, registered address)
- VMI (Valstybinė mokesčių inspekcija) – VAT registry lookup for Lithuanian companies
- Rekvizitai.lt – Lithuanian business directory listing for Hollister Lietuva UAB (financial snapshots, contacts if published)

Where exact identifiers or contacts are marked “not verified,” readers are encouraged to confirm directly in the official registries or the company’s current public communications, as these details can change and may not be consistently mirrored across secondary sources.